The prevalence of Cryptosporidium spp. infection in a cross-sectional study of dairy cattle, from two contrasting dairying regions in Tanzania, were determined by staining smears of faecal samples with the modified Ziehl-Neelsen technique. Of the 1 126 faecal samples screened, 19.7% were positive for Cryptosporidium spp. The prevalence was lower in Tanga Region than in Iringa Region. The prevalence of affected farms was 20% in Tanga and 21% in Iringa. In both regions, the probability of detecting Cryptosporidium oocysts in faeces varied with animal class, but these were not consistent in both regions. In Tanga Region, Cryptosporidium oocysts were significantly more likely to be found in the faeces of milking cows. In Iringa Region, the likelihood that cattle had Cryptosporidium-positive faeces declined with age, and milking cattle were significantly less likely to have Cryptosporidium positive faeces. In this region, 7% of cattle were housed within the family house at night, and this was marginally associated with a higher likelihood that animals had Cryptosporidium-positive faeces. Our study suggests that even though herd sizes are small, Cryptosporidium spp. are endemic on many Tanzanian smallholder dairy farms. These protozoa may impact on animal health and production, but also on human health, given the close associations between the cattle and their keepers. Further studies are required to assess these risks in more detail, and understand the epidemiology of Cryptosporidium spp. in this management system.

The length of the antibiotic withdrawal period after intramammary treatment was influenced by the milk yield of dairy goats during this trial. Shorter withdrawal periods were seen in relatively high yielding dairy goats (production above 1.5 ℓ per day) compared to low producers (less than 1.3 ℓ per day). High yielding goats treated with Curaclox LC (Norbrook [Pharmacia AH]) had a withdrawal period of 42 h, while low yielding goats, treated with the same product, had a withdrawal period of 74 h. The recommended withdrawal period for Curaclox LC for use in cattle is 72 h. Relatively high yielding goats treated with Rilexine 200 LC (Logos Agvet [Virbac]) had a significantly shorter withdrawal period (37 h) than that recommended for use in cattle (96 h). Low yielding goats treated with Spectrazol Milking Cow (Schering-Plough Animal Health) had a significantly longer (95 h) withdrawal period than that recommended for use in cattle (60 h). Withdrawal periods were also influenced by stage of lactation and parity. There was a moderate positive correlation between lactation number and withdrawal period, as measured by TRIS (R2 = 0.621), and a moderate negative correlation between stage of lactation and withdrawal period (R2 = -0.669). In Trials 1, 2 and 3 combined there was a moderate negative correlation between withdrawal period and volume (R2 = -0.511) and a strong positive correlation between withdrawal period and lactation number (R2 = 0.720). The differences in percentage milk fat, protein and lactose before, during and after treatment were not statistically significant except in Trial 3 (Curaclox LC and Rilexine 200 LC) where protein and lactose differed significantly. In Trial 2 (Spectrazol Milking Cow) milk fat percentages differed significantly between treatment and control groups as did protein percentages in Trial 3. These differences are however, not biologically meaningful.

Sixty, day-old, chicks were reared up to 3 weeks of age and then randomly divided into 4 equal groups (3 treated and one control group). Urea (46 % nitrogen) was added to the grower-finisher ration of the treated birds at levels of 1% , 3% and 5% (groups I, II & III respectively). Feed and water were available ad libitum for all birds over the time of experiment. At days 7, 20 and 30 post exposure, 5 birds from each group were weighed, bled and sacrificed. All birds spontaneously died during the experiment were also necropsied. Haematological parameters (RBCs, WBCs counts, PCV and Hb), biochemical variables [urea, glucose, uric acid, alkaline phosphatase; (ALP) and lactate dehydrogenase; (LDH)] and body weight gain were assessed. The encountered pathological changes were described. The obtained results indicated that: (1) decrease in RBCs, WBCs counts, PCV and Hb, (2) increase in ALP, LDH, urea and uric acid, while glucose level was decreased. (3) decrease in body weight gain in all treated birds. There were significant pathological changes in kidneys, heart, liver and lungs of the treated birds. It was concluded that addition of urea to poultry feeds to replace the more expensive protein-nitrogen has serious consequences which affect the health condition and weight gain of birds.

Some pharmacokinetic aspects of sulphadoxine alone and sulphadoxine-trimethoprim (TMP) combination were studied in goats following single intravenous (i.v) and intramuscular (i.m) administration of 15 mg kg–1 b.wt. After i.v injection the serum sulphadoxine concentration time course was best described by two compartment-open model with distribution half-lives (t0.5(.)) 2.48 and 2.31 h., elimination (t0.5(3)) half-lives 23.10 and 24.75 h., total body clearance (ClB) 0.076 and 0.073 L kg-1 h.-1 and steady state volume of distribution (Vdss) 368.54 and 411.73 ml kg-1 for sulphadoxine alone and sulphadoxine-trimethoprim combination, respectively. After i.m administration the mean peak serum concentrations (Cmax) 25.69 and 33.31 ug ml–1 were achieved after maximum time (tmax) of 3.09 and 2.79 h. for sulphadoxine alone and sulphadoxinetrimethoprim combination, respectively. The absorption half-lives (t0.5(ab)) were 0.58 and 0.42 h., respectively. It is concluded that a combination of sulphadoxine and TMP can provide a synergistic level for both antimicrobials and thus be a useful combination in the treatment of various goat diseases.

A total of 620 egg samples from different species (chickens, ducks and ostriches) and 1615 poultry samples (chickens, ducks, pigeons, quails, turkeys and ostriches) were examined for salmonella infection. 12 salmonella isolates were obtained from the egg samples (1.9%) and 67 isolates from poultry samples (4.1%). Salmonella isolates were serotyped into S. enteritidis (25 isolates), S. typhimurium (17 isolates), S. infantis (12 isolates), S. montivideo (7 isolates), 3 isolates for each of S. rubislaw and S. cerro , 2 isolates for each of S. virginia, S. agona, S. poona, and S. derby and 1 isolate for each of S. sandiago and S. kentucky. The incidence of isolation from different poultry species was discussed in details. Antibiogram of the isolated salmonellae against 10 different antibiotics revealed that norofloxacin, ciprofloxacin, cepheridin and gentamycin gave the highest activity against different salmonella isolates while amoxicillin, tetracycline, and nitrofurantoin showed the highest resistance rate. Pathogenicity of the isolated serovars was tested in chickens. All isolates were found pathogenic with various degree of virulence. SDSPAGE protein analysis for the salmonella isolated form different poultry species revealed 12 protein bands ranged from 22-289 kDa. The differences were insufficient for reliable differentiation between the isolates and accordingly, it could be used beside other molecular techniques in differentiation between the salmonella strains.

This study was carried out on 68 randomly collected chickens located at Ras Sedr Research Station, Desert Research Center, 68 serum samples were examined serologically by complement fixation test (CFT). Twenty out of 68 (29.91%) had antibodies against Chlamydophila psittaci . Ten blood samples of the serologically positive cases were subjected to polymerase chain reaction (PCR) and showed positive results for Chlamydophila psittaci at 119 bp. Therefore PCR was found to be reliable, rapid, sensitive and specific technique for the detection Chlamydophila psittaci in birds. Serologically positive birds did not show any clinical symptoms of disease, but they were in contact with sheep and goat that showed previous abortion and were positive for C. abortus. It is recommended to avoid breeding of chickens with other animal species in the same yard because chickens become asymptomatic carrier with shedding of Chlamydophila psittaci in their feaces and respiratory discharges.

The pharmacokinetic profile of ceftiofur sodium, a third generation cephalosporin, was studied in both Friesian and buffalo calves following a single intravenous and intramuscular administration of 2.2 mg kg-1 b.wt. in a cross over study with 15-day wash out period. After i.v administration the serum concentration-time curve of ceftiofur sodium was best fitted using two-compartments open model, with distribution half-lives (t½(()) of 0.384 and 0.176 h., elimination half-lives (t½(0)) of 5.047 and 1.607 h., mean residence time (MRT) of 6.926 and 2.072 h., volumes of distribution at steady-state (Vdss) of 0.206 and 0.134 L kg-1 and total body clearance (ClB) of 0.029 and 0.065 L kg-1 h-1 in Friesian and buffalo calves, respectively. Following intramuscular administration, the drug absorbed with half-lives of absorption (t½(ab)) of 1.010 and 0.217 h., maximum serum concentrations (Cmax) of 5.539 and 9.663 g ml-1 which attained after (tmax) of 3.147 and 0.825 h. and the drug was eliminated with half-lives (t½(el)) of 5.239 and 1.750 h. in Friesian and buffalo calves, respectively. The systemic intramuscular bioavailabilities were 89.82 and 99.7 %, while the in-vitro serum proteinbinding tendencies were 39.68 and 14.44 % in Friesian and buffalo calves, respectively

This study was carried out on 168 sheep in a private farm at Qena province. 128 out of them were apparently healthy, 22 clinically diseased suffering from respiratory affections and 18 were died at three weeks intervals. Bacteriological examination of the samples revealed that 42 samples were positive for bacterial isolation; 6 from apparently healthy animals, 20 from clinically diseased animals and 16 from dead ones. Bacterial isolates could be identified biochemically as P. multocida and P. heamolytica. Pathogenicity tests for P. multocida isolates indicated that the isolates were pathogenic to laboratory animals. P. multocida was isolated in high percentage (15%) in comparing with P. haemolytica (10%).

A total number of 28 buffaloes aged between 5-7years, body weight ranged between 400-500 kg, and belonged to private farms at Assiut Governorate constituted the materials of this study. Twenty of them showed the classical signs of hypophosphataemia while the other eight buffaloes were proved to be healthy by both clinical and laboratory investigations, used as control group. Biochemical analysis of blood sera showed a highly significant hypophosphataemia, hypocalcaemia and hypomagnesaemia in diseased buffaloes either pre or post treatment when compared with the healthy control ones. Meanwhile, the examination of blood showed marked decreases in erythrocytic count, haemoglobin concentration and packed cell volume in diseased animals. All parameters improved in affected buffaloes after 10 days of treatment. The chemical analysis of agronomical samples of soil and drinking water were done. The statistical analyses between the studied parameters were carried out in buffaloes before and after treatment.

The urinary bladder of 15 clinically normal dogs was excised and the ureters were implanted into an isolated, vagotomized gastric segment derived from the fundic region of the stomach. The gastric segment was closed to form a neobladder. Continence was maintained with a "nipple valve" created at the tubularized end of isolated segment of stomach. Clinical, radiological, ultrasonographical, urine and blood analysis and histopathological examination were carried out for assessment of the technique. Eleven cases showed an apparently normal bladder function. Two cases suffered from renal hydronephrosis and other two suffered from incontinence. It was concluded that gastric neobladder urinary diversion is satisfactory for clinical use in dogs.